Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02536339
Title A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Genentech, Inc.
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Arizona Cancer Center Tucson Arizona 85719 United States Details
City of Hope National Medical Center Duarte California 91010 United States Details
Stanford Cancer Institute Stanford California 94305 United States Details
University of Miami Hospital & Clinics Miami Florida 33136 United States Details
H. Lee Moffitt Cancer Center and Research Inst. Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60611-2987 United States Details
University of Maryland Medical Center; Department of Neurology Baltimore Maryland 21201 United States Details
Associates in Oncology-Hematology, PC Bethesda Maryland 20817 United States Details
Dana Farber Cancer Inst. Boston Massachusetts 02115 United States Details
Allina Health System Saint Paul Minnesota 55102 United States Details
Stony Brook University Medical Center Stony Brook New York 11794 United States Details
Mid Ohio Oncology Hematology;ZangMeister Center (West) Columbus Ohio 43213 United States Details
Temple Cancer Center; Oncology Philadelphia Pennsylvania 19140 United States Details
Methodist Hospital Research Institute Houston Texas 77030 United States Details
Huntsman Cancer Institute; University of Utah Salt Lake City Utah 84112 United States Details
Northwest Medical Specialties, PLLC Tacoma Washington 98405 United States Details
*Shaded cells indicate that there was no data available from for the field